微创血肿清除术治疗高血压脑出血病死率分析

Analysis of Mortality of Hypertensive Cerebral Hemorrhage Treated with Micro-invasive Evacuation of Hematoma

目的探讨微创血肿清除术对高血压性脑出血(HICH、30～80ml)病死率的影响。方法回顾性分析符合入选标准的高血压性脑出血患者136例(微创组67例,对照组69例),对两组患者病死率进行对照研究。结果①微创组死亡6例,病死率为8.9%,对照组死亡20例,病死率为28.9%(χ2=4.348,P=0.034),差异有统计学意义。②比较微创组和对照组死亡原因时,死于单纯脑疝的分别是33.3%和70.0%(χ2=4.803,P=0.025),差异有统计学意义。结论微创血肿清除术治疗高血压性脑出血能降低患者的病死率,是治疗高血压性脑出血较为理想的手术方法。

Objective To investigate the impact of mini-invasive evacuation of hematoma on mortality of hypertensive cerebral hemorrhage （HICH ,30-80ml）. Methods 67 patients with HICH （surgical group）were treated with micro-invasive evacuation of hematoma, and 69 patients （control group）that matched with the surgical group in age, GCS, position and volume of intra-cerebral hematoma were treated with drug therapy only. The mortality of the two groups were analyzed. Results The difference of mortality between two groups was significant （ 8.9% vs 28.9% , χ2 = 4. 348, P = 0.034 ）. The difference of the reason of dying from single cerebral hernia between two groups was significant （ 33.3% vs 70, 0%, χ2 = 4.803,P = 0. 025 ）. Conclusion Micro-invasive evacuation of hematoma was an ideal surgical therapy to treat patients with HICH.